YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Serum triglycerides level is independently associated with renal outcomes in patients with non-dialysis chronic kidney disease: Results from KNOW-CKD study	FRONTIERS IN NUTRITION
2022	Multifunctional microrobot with real-time visualization and magnetic resonance imaging for chemoembolization therapy of liver cancer	SCIENCE ADVANCES
2022	Life-threatening cardiac arrhythmia and sudden death during electronic gaming: An international case series and systematic review	HEART RHYTHM
2022	Redundant Electromagnetic Control of an Endoscopic Magnetic Capsule Driven by Multiple Electromagnets Configuration	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS
2022	A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention	JOURNAL OF INVASIVE CARDIOLOGY
2022	Factors Related to Hospital Readmission of Frail Older Adults in Korea	YONSEI MEDICAL JOURNAL
2022	Sex disparities in mortality among patients with kidney failure receiving dialysis	SCIENTIFIC REPORTS
2022	Reduced Mortality With Antiplatelet Therapy Deescalation After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis	CIRCULATION-CARDIOVASCULAR INTERVENTIONS
2022	Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07	JOURNAL OF CLINICAL ONCOLOGY
2022	Nationwide Trends of Gatekeeper to Invasive Coronary Angiography in Suspected Coronary Artery Disease	KOREAN CIRCULATION JOURNAL
2022	Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2022	Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study	CANCERS
2022	9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea	LANCET
2022	Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients : A Nationwide Propensity Score-Weighted Study	ANNALS OF INTERNAL MEDICINE
2022	BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling	NATURE COMMUNICATIONS
2022	Quality reporting of radiomics analysis in pituitary adenomas: promoting clinical translation	BRITISH JOURNAL OF RADIOLOGY
2022	A novel anti-cancer compound development targeting YAP-TEAD protein-protein interaction	EUROPEAN JOURNAL OF CANCER
2022	Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum	Clinical Hypertension
2022	Update from the ongoing phase 1/2 registrational trial of repotrectinib: results in TKI-naïve and TKI-pretreated patients with NTRK fusion-positive advanced solid tumors (TRIDENT-1)	EUROPEAN JOURNAL OF CANCER
2022	A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)	EUROPEAN JOURNAL OF CANCER